Form 8-K - Current report:
SEC Accession No. 0001079973-25-000774
Filing Date
2025-05-08
Accepted
2025-05-08 16:55:27
Documents
14
Period of Report
2025-05-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 36938
  Complete submission text file 0001079973-25-000774.txt   260139

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE toi-20250507.xsd EX-101.SCH 3911
3 XBRL DEFINITION FILE toi-20250507_def.xml EX-101.DEF 26803
4 XBRL LABEL FILE toi-20250507_lab.xml EX-101.LAB 37032
5 XBRL PRESENTATION FILE toi-20250507_pre.xml EX-101.PRE 25427
16 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 6174
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 25927138
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)